Daniel Fred Goodman, M.D.November 25, 2024

FDA 483 - Daniel Fred Goodman, M.D. - November 25, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Daniel Fred Goodman, M.D.

Record Details

The FDA inspected Daniel Fred Goodman, M.D., a clinical investigator in San Francisco, CA, from November 20-25, 2024. The inspection revealed that the clinical investigator failed to properly investigate and document protocol deviations, specifically neglecting to assess their impact on subject safety and data integrity. This indicates a serious lapse in adherence to investigational plans and regulatory requirements.

Company: Daniel Fred Goodman, M.D.
Inspection Date: November 25, 2024
Product Type: Other
Office: San Francisco District Office
Person: Scott N. Lim

Open in Dashboard

ID · 1ba20ce0-0f7f-4212-a7e0-54ef4c603d0d